Catalyst Pharmaceuticals Inc (CPRX)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 2.71B
P/E Ratio
14.15
Revenue (TTM)
$ 534.65M
Volume
0
52W High
$ 26.58
52W Low
$ 17.58
Dividend Yield
0.00%
Beta
0.70
Technicals
50-Day MA
22.5598
200-Day MA
22.5012
52 Week High
26.58
52 Week Low
17.58
About CPRX
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States.
Employees
181
Headquarters
Coral Gables, FL
CEO
Mr. Richard John Daly M.B.A.
Latest News
CPRX or STVN: Which Is the Better Value Stock Right Now? - Yahoo Finance
4 weeks ago • Google News
Catalyst (CPRX) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates - sharewise.com
5 hours ago • Google News